These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2379540)

  • 1. Excretion of tolbutamide metabolites in young and old subjects.
    Miller AK; Adir J; Vestal RE
    Eur J Clin Pharmacol; 1990; 38(5):523-4. PubMed ID: 2379540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolbutamide hydroxylation in humans: lack of bimodality in 106 healthy subjects.
    Veronese ME; Miners JO; Rees DL; Birkett DJ
    Pharmacogenetics; 1993 Apr; 3(2):86-93. PubMed ID: 8518838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochrome P450 2C9 phenotyping using low-dose tolbutamide.
    Jetter A; Kinzig-Schippers M; Skott A; Lazar A; Tomalik-Scharte D; Kirchheiner J; Walchner-Bonjean M; Hering U; Jakob V; Rodamer M; Jabrane W; Kasel D; Brockmöller J; Fuhr U; Sörgel F
    Eur J Clin Pharmacol; 2004 May; 60(3):165-71. PubMed ID: 15045499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of relationship between tolbutamide metabolism and debrisoquine oxidation phenotype.
    Peart GF; Boutagy J; Shenfield GM
    Eur J Clin Pharmacol; 1987; 33(4):397-402. PubMed ID: 3443146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of tolbutamide in ethnic Chinese.
    Gross AS; Bridge S; Shenfield GM
    Br J Clin Pharmacol; 1999 Feb; 47(2):151-6. PubMed ID: 10190649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the tolbutamide metabolic ratio for population screening with use of sulfaphenazole to produce model phenotypic poor metabolizers.
    Veronese ME; Miners JO; Randles D; Gregov D; Birkett DJ
    Clin Pharmacol Ther; 1990 Mar; 47(3):403-11. PubMed ID: 2311340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microdose pharmacogenetic study of ¹⁴C-tolbutamide in healthy subjects with accelerator mass spectrometry to examine the effects of CYP2C9∗3 on its pharmacokinetics and metabolism.
    Ikeda T; Aoyama S; Tozuka Z; Nozawa K; Hamabe Y; Matsui T; Kainuma M; Hasegawa S; Maeda K; Sugiyama Y
    Eur J Pharm Sci; 2013 Jul; 49(4):642-8. PubMed ID: 23727057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous determinations of tolbutamide and its hydroxy and carboxy metabolites in serum and urine: application to pharmacokinetic studies of tolbutamide in the rat.
    St-Hilaire S; Belanger PM
    J Pharm Sci; 1989 Oct; 78(10):863-6. PubMed ID: 2600795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A screening test for slow metabolisers of tolbutamide.
    Page MA; Boutagy JS; Shenfield GM
    Br J Clin Pharmacol; 1991 Jun; 31(6):649-54. PubMed ID: 1867959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of carboxytolbutamide excretion following tolbutamide and carboxytolbutamide administration.
    NELSON E; O'REILLY I
    J Pharmacol Exp Ther; 1961 Apr; 132():103-9. PubMed ID: 13728274
    [No Abstract]   [Full Text] [Related]  

  • 11. Simultaneous determination of tolbutamide and its hydroxy and carboxy metabolites in plasma and urine by high-performance liquid chromatography.
    Keal J; Stockley C; Somogyi A
    J Chromatogr; 1986 May; 378(1):237-41. PubMed ID: 3733977
    [No Abstract]   [Full Text] [Related]  

  • 12. High-performance liquid chromatographic assay of tolbutamide and carboxytolbutamide in human plasma.
    Raghow G; Meyer MC
    J Pharm Sci; 1981 Oct; 70(10):1166-8. PubMed ID: 7299655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A species comparison of tolbutamide metabolism in precision-cut liver slices from rats and dogs. Qualitative and quantitative sex differences.
    Dogterom P; Rothuizen J
    Drug Metab Dispos; 1993; 21(4):705-9. PubMed ID: 8104131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new aspect of tolbutamide metabolism in the rabbit: the role of 1-butyl-3-(p-formylphenyl)sulphonylurea.
    Washio K; Makaya O; Sasaki H; Nishida K; Nakamura J; Shibasaki J
    J Pharm Pharmacol; 1993 Mar; 45(3):231-3. PubMed ID: 8483106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liquid chromatography/tandem mass spectrometry method for simultaneous evaluation of activities of five cytochrome P450s using a five-drug cocktail and application to cytochrome P450 phenotyping studies in rats.
    Zhang S; Song N; Li Q; Fan H; Liu C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Aug; 871(1):78-89. PubMed ID: 18614408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of cytochrome P4502C9 metabolic activity with tolbutamide in CYP2C91 heterozygotes.
    Lee CR; Pieper JA; Hinderliter AL; Blaisdell JA; Goldstein JA
    Clin Pharmacol Ther; 2002 Nov; 72(5):562-71. PubMed ID: 12426520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of inhibition of tolbutamide hydroxylation by cimetidine in man.
    Stockley C; Keal J; Rolan P; Bochner F; Somogyi A
    Eur J Clin Pharmacol; 1986; 31(2):235-7. PubMed ID: 3803421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective inhibition of drug oxidation after simultaneous administration of two probe drugs, antipyrine and tolbutamide.
    Back DJ; Tjia J; Mönig H; Ohnhaus EE; Park BK
    Eur J Clin Pharmacol; 1988; 34(2):157-63. PubMed ID: 3383988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aging and drug interactions. II. Effect of phenytoin and smoking on the oxidation of theophylline and cortisol in healthy men.
    Crowley JJ; Cusack BJ; Jue SG; Koup JR; Park BK; Vestal RE
    J Pharmacol Exp Ther; 1988 May; 245(2):513-23. PubMed ID: 3367304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of age and sex on metabolism and urinary excretion of antipyrine.
    Jorquera F; Almar M; Pozuelo M; Sansegundo D; González-Sastre M; González-Gallego J
    J Gerontol A Biol Sci Med Sci; 1998 Jan; 53(1):M14-9. PubMed ID: 9467428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.